Procaps Group (NASDAQ:PROC) Shares Gap Down to $7.50

Shares of Procaps Group, S.A. (NASDAQ:PROCGet Rating) gapped down before the market opened on Tuesday . The stock had previously closed at $7.50, but opened at $6.92. Procaps Group shares last traded at $6.92, with a volume of 100 shares traded.

Separately, Zacks Investment Research downgraded Procaps Group from a “buy” rating to a “hold” rating in a research note on Tuesday, February 22nd.

The company has a quick ratio of 0.85, a current ratio of 1.13 and a debt-to-equity ratio of 3.12. The company has a 50 day moving average of $8.29.

Several hedge funds have recently made changes to their positions in the company. Compass Group LLC acquired a new position in Procaps Group in the 3rd quarter valued at $7,687,000. Sectoral Asset Management Inc acquired a new position in Procaps Group in the 3rd quarter valued at $2,798,000. Berkley W R Corp acquired a new position in Procaps Group in the 3rd quarter valued at $3,344,000. Citadel Advisors LLC acquired a new position in Procaps Group in the 3rd quarter valued at $458,000. Finally, Credit Suisse AG acquired a new position in Procaps Group in the 4th quarter valued at $169,000. 1.72% of the stock is owned by institutional investors and hedge funds.

About Procaps Group (NASDAQ:PROC)

Procaps Group, SA operates as an integrated healthcare and pharmaceutical company worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.

Read More

Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.